Angiostatin suppresses malignant glioma growth in vivo

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4654-4659

  Kirsch, Matthias ^a,b   Strasser, Jon ^a   Allende, Rafael ^a   Bello, Lorenzo ^a   Zhang, Jianping ^a   Black, Peter McL ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; DNA; MESSENGER RNA; PLASMINOGEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ENDOTHELIAL GROWTH FACTORS; GLIOMA; HUMANS; LYMPHOKINES; MALE; MICE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; RATS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032532393     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Black, P. M. Brain tumors. Part I. N. Engl. J. Med., 324: 1471-1476, 1991.
2. Leon, S. P., Folkerth, R. D., and Black, P. M. Microvessel density is a prognostic indicator in patients with astroglial brain tumors. Cancer (Phila.), 77: 362-372, 1996.
3. Brem, H., Thompson, D., Long, D. M., and Patz, A. Human brain tumors: differences in ability to stimulate angiogenesis. Surg. Forum, 31: 471-476, 1980.
4. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
5. Takamiya, Y., Brem, H., Ojeifo, J., Mineta, T., and Martuza, R. L. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery (Baltimore), 34: 869-875, 1994.
6. Lee, J. K., Choi, B., Sobel, R. A., Chiocca, E. A., and Martuza, R. L. Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone. J. Neurosurg., 73: 429-435, 1990.
7. Weingart, J. D., Sipos, E. P., and Brem, H. The role of minocycline in the treatment of intracranial 9L glioma. J. Neurosurg., 82: 635-640, 1995.
8. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M. L. W., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
9. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
10. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
11. Chirgwin, J. M., Przbyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched with ribonuclease. Biochemistry, 18: 5294-5299, 1979.
12. Carroll, R. S., Black, P. M., Zhang, J., Kirsch, M., Percec, I., Lau, N., and Guha, A. Expression and activation of epidermal growth factor receptors in meningiomas. J. Neurosurg., 87: 315-323, 1997.
13. Senger, D. R., Van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
14. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
15. Plate, K H., Breier, G., and Risau, W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol., 4: 207-218, 1994.
16. Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U., and Oldfield, E. H. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest., 91: 153-159, 1993.
17. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res., 53: 5822-5827, 1993.
18. Plate, K. H., Breier, G., Welch, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
19. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
20. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
21. Bowen-Pope, D. F., DiCorleto, P. E., and Ross, R. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor. J. Cell Biol., 96: 679-683, 1983.
22. Westphal, M., and Herrmann, H. D. Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery (Baltimore), 25: 681-694, 1989.
23. Fleming, T. P., Saxena, A., Clark, W. C., Robertson, J. T., Oldfield, E. H., Aaronson, S. A., and Ali, I. U. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res., 52: 4550-4553, 1992.
24. Nister, M., Libermann, T. A., Betsholtz, C., Pettersson, M., Claesson-Welsh, L. H. C., Schlessinger, J., and Westermark, B. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res., 48: 3910-3918, 1988.
25. Schreiber, A. B., Winkler, M. E., and Derynck, R. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science (Washington DC), 232: 1250-1253, 1986.
26. Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fujita, T., and Kozai, Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51: 6180-6184, 1991.
27. Samoto, K., Ikezaki, K., Ono, M., Shono, T., Kohno, K., Kuwano, M., and Fukui, M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res., 55: 1189-1193, 1995.
28. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
29. Boehm, T., Folkman, J., Browder, T., and O'Reilly. M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.